Carlsmed Raises FY2026 Sales Guidance from $72.000M-$77.000M to $74.000M-$78.000M vs $74.830M Est
Carlsmed (NASDAQ: CARL ) raises FY2026 sales outlook from $72.000 million-$77.000 million to $74.000 million-$78.000 million vs $74.830 million estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.